Poland· PL-100132187
Syrop z sulfogwajakolem
A medicinal product containing sulfogaiacoli sirupus, registered in Poland by Poznańskie Zakłady Zielarskie "Herbapol" S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Sulfogaiacoli sirupus
- Manufacturer
- Poznańskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990022885
- gtin05909990022908
- gtin05909990022939
- gtin05909990022946
- gtin05909990022892
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e778ae80-96d5-4516-8098-6c7167df7c9f GET /v1/drugs/e778ae80-96d5-4516-8098-6c7167df7c9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "6%",
"packaging": "05909990022885 ¦ OTC ¦ 34676\n1 butelka 100 g\n05909990022908 ¦ OTC ¦ 34677\n1 butelka 150 g\n05909990022939 ¦ OTC ¦ 34678\n1 butelka 250 g\n05909990022946 ¦ OTC ¦ Skasowane ¦ 34679\n1 op. 650 g\n05909990022892 ¦ OTC ¦ 45988\n1 butelka 125 g",
"substance": "Sulfogaiacolum 6 g",
"common_name": "Sulfogaiacoli sirupus",
"pl_product_id": "100132187",
"pozwolenie_nr": "IL-4466/ChF",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about sulfogaiacoli sirupus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.